-
Signature
-
/s/ Flor Colon, Attorney-in-Fact
-
Stock symbol
-
XRX
-
Transactions as of
-
Feb 3, 2023
-
Transactions value $
-
$0
-
Form type
-
4/A - Amendment
-
Date filed
-
2/21/2023, 05:40 PM
-
Date Of Original Report
-
Feb 3, 2023
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
XRX |
Restricted Stock Units |
Award |
$0 |
+41.7K |
+167.71% |
$0.00 |
66.6K |
Jan 18, 2023 |
Direct |
F1 |
transaction |
XRX |
Restricted Stock Units |
Award |
$0 |
+21K |
+31.55% |
$0.00 |
87.5K |
Jan 19, 2023 |
Direct |
F2 |
holding |
XRX |
Restricted Stock Units |
|
|
|
|
|
57.6K |
Feb 3, 2023 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The original Form 4 filed on January 20, 2023 is being amended solely to correct an administrative error which overstated the grant amount and understated the beneficial ownership of Restricted Stock Units by 3,574 units and overstated the beneficial ownership of Common Stock by 700 shares. The number of Restricted Stock Units and Common Stock beneficially owned by the Reporting Person as reported in Table I, Column 5 of the subsequent Form 4 filed on February 7, 2023 is similarly understated by 3,574 Restricted Stock Units, and overstated by 700 shares of Common Stock. As of February 21, 2023, the Reporting Person beneficially owns 85,536 shares of Restricted Stock Units and 58,996 shares of Common Stock.